![Joseph Palumbo](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Joseph Palumbo
Directeur Technique/Scientifique/R&D chez
BIOVIE INC.
Fortune : 1 552 $ au 31/05/2026
Profil
Joseph M.
Palumbo currently serves as Chief Medical Officer, EVP-Research & Development at BioVie, Inc. since 2021 and as Chief Medical Officer at Option Therapeutics, Inc. Formerly, Dr. Palumbo was Chief Medical Officer & Vice President at Zynerba Pharmaceuticals, Inc. from 2019 to 2021, Vice President-US Medical Science at Tanabe Pharma Corp., and Head-Global & Franchise Medical at Johnson & Johnson.
Education includes undergraduate studies at the University of Pennsylvania Graduate School of Education and a doctorate from George Washington University School of Medicine & Health.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
BIOVIE INC. CLASS A 0,01 % | 05/01/2026 | 1 093 ( 0,01 % ) | 1 552 $ | 31/05/2026 |
Postes actifs de Joseph Palumbo
| Sociétés | Poste | Début |
|---|---|---|
| BIOVIE INC. | Directeur Technique/Scientifique/R&D | 01/11/2021 |
Anciens postes connus de Joseph Palumbo
| Sociétés | Poste | Fin |
|---|---|---|
| ZYNERBA PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 01/10/2021 |
| JOHNSON & JOHNSON | Corporate Officer/Principal | - |
| MITSUBISHI TANABE PHARMA CORPORATION | Corporate Officer/Principal | - |
Formation de Joseph Palumbo
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
5
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Johnson & Johnson
 Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
Zynerba Pharmaceuticals, Inc.
 Zynerba Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Delivers dermal solutions for the treatment of neuroscience disorders | Health Technology |
BioVie, Inc.
 BioVie, Inc. BiotechnologyHealth Technology Develops drug therapies for chronic debilitating conditions | Health Technology |
Mitsubishi Tanabe Pharma Corp.
 Mitsubishi Tanabe Pharma Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical products | Health Technology |
University of Pennsylvania Graduate School of Education
 University of Pennsylvania Graduate School of Education Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
George Washington University School of Medicine & Health
 George Washington University School of Medicine & Health Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Choisissez Zonebourse 
